BAKER BROS. ADVISORS LP is a New York-based hedge fund management firm founded in 2000 by brothers Julian and Felix Baker, best known for its concentrated focus on biotechnology and healthcare investing. It manages a large institutional portfolio, with recent public data showing roughly $17.1 billion in disclosed 13F holdings and 86 positions, and it is widely regarded as one of the most influential healthcare-focused investors in the market.
Julian Baker is the cofounder and managing partner of Baker Bros. Advisors LP, the biotechnology-focused investment firm he launched with his brother in 2000; he is known for long-term investing in life-sciences companies and has also served on the boards of several biopharma firms.
Felix Baker is the cofounder and managing member of Baker Bros. Advisors LP, with a Ph.D. in immunology from Stanford; he also focuses on biotechnology investing and serves on the boards of multiple biotech companies, reflecting the firm’s deep specialization in the sector.
Nil
Companies with fund stakes involved in activist actions such as 13D filing(s) or proxy campaign(s).